Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TASC: Therapeutic Anticoagulation Strategy for Acute Chest Syndrome in Adults
NCT02580773Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2016
- Primary completion
- Feb 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of tinzaparin in acute chest syndrome (ACS), sponsored by Assistance publique - Hôpitaux de Paris. Started Dec 2016; status: completed.
02
Drugs
tinzaparin
03
Conditions
acute chest syndrome (ACS)
Beyond the preview
Go deeper on NCT02580773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02580773.